|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net increase (decrease) in net assets resulting from operations | ||||
| Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities: | ||||
| Net change in unrealized (appreciation) depreciation on investments | ||||
| Non-controlled/non-affiliated investments | ||||
| Non-controlled/affiliated investments | ||||
| Total net change in unrealized (appreciation) depreciation on investments | ||||
| Net change in unrealized (appreciation) depreciation on derivative instruments | ||||
| Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies | ||||
| Net realized (gain) loss on investments | ||||
| Non-controlled/non-affiliated investments | ||||
| Non-controlled/affiliated investments | ||||
| Total net realized (gain) loss on investments | ||||
| Net change due to hedging activity | ||||
| Net realized (gain) loss on foreign currency transactions | ||||
| Net accretion of discount and amortization of premium | ||||
| Payment-in-kind interest capitalized | ||||
| Amortization of deferred financing costs | ||||
| Amortization of original issue discount and debt issuance costs (including premiums and discounts) | ||||
| Purchases of investments | ||||
| Proceeds from sale of investments and principal repayments | ||||
| Changes in operating assets and liabilities: | ||||
| Interest receivable | ||||
| Non-controlled/non-affiliated investments | ||||
| Non-controlled/affiliated investments | ||||
| Total interest receivable | ||||
| Receivable for investments | ||||
| Derivative instruments, net | ||||
| Other assets | ||||
| Receivable from broker | ||||
| Payable for investments | ||||
| Due to affiliates | ||||
| Management fees payable | ||||
| Income based incentive fees payable | ||||
| Capital gains based incentive fees payable | ||||
| Interest payable | ||||
| Accrued expenses and other liabilities | ||||
| Net cash provided by (used in) operating activities | ||||
| Cash flows from financing activities: | ||||
| Borrowings on debt | ||||
| Repayments on debt | ||||
| Deferred financing costs paid | ||||
| Debt issuance costs paid | ||||
| Deferred offering costs paid on issuance of common shares | ||||
| Dividends paid in cash | ||||
| Proceeds from issuance of Common Shares, net of offering and underwriting costs | ||||
| Redemptions paid in cash | ||||
| Net cash provided by (used in) financing activities | ||||
| Net increase (decrease) in cash and cash equivalents | ||||
| Effect of foreign exchange rate changes on cash and cash equivalents | ||||
| Cash and cash equivalents (including restricted cash), beginning of period | ||||
| Cash and cash equivalents (including restricted cash), end of period | ||||
| Supplemental information and non-cash activities: | ||||
| Interest paid during the period | ||||
| Distribution payable | ||||
| Reinvestment of distributions during the period | ||||
| Non-cash deferred financing costs activity | ||||
| Accrued but unpaid debt issuance costs | ||||
| Accrued but unpaid debt issuing costs | ||||
| Receivable for shares sold | ||||
| Excise and other taxes paid | ||||
Loading...